首页> 美国卫生研究院文献>Evidence-based Complementary and Alternative Medicine : eCAM >Hydroethanolic Extracts of Erigeron floribundus and Azadirachta indica Reduced Plasmodium berghei Parasitemia in Balb/c Mice
【2h】

Hydroethanolic Extracts of Erigeron floribundus and Azadirachta indica Reduced Plasmodium berghei Parasitemia in Balb/c Mice

机译:灯盏花和印度印za的乙醇提取物可降低Balb / c小鼠的伯氏疟原虫寄生性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Malaria is one of the most important infectious diseases in Africa especially in Cameroon. The nonaccessibility to current treatments for poor people and the appearance of drug-resistant Plasmodium falciparum parasites stimulate the search for alternative treatments. The aim of this study was to evaluate the antimalarial activity and the safety of hydroethanolic extracts from Erigeron floribundus and Azadirachta indica. The crude hydroethanolic extracts of E. floribundus (HEEF) and A. indica (HEAI) were prepared via maceration of the whole plant powder of E. floribundus and the leaves of A. indica in 70% ethanol. The antimalarial activity was determined according to Peter's 4-day suppressive test using the murine model Plasmodium berghei/Balb C mice, while the acute and subacute toxicity tests were assessed according to the OECD 425 and 407 guidelines, respectively. The results indicate a reduction of parasitemia ranging from 49.75 ± 3.64 to 69.28 ± 1.36% for HEAI and from 30.46 ± 4.30 to 62.36 ± 2.32% for HEEI. Overall, HEEF and HEAI at doses of 60, 120, and 240 mg/kg b.w. and 75, 150, and 300 mg/kg b.w., respectively, showed a significant (p≤0.001) parasitemia reduction on P. berghei infecting BALB/c mice. HEEF and HEAI caused a significant (p<0.001) attenuation of body temperature drop in mice compared to negative control, except for the 150 mg/kg b.w. dose in the female group. Moreover, there was no mice mortality observed with these extracts even at 5000 mg/kg, while the aspartate amino transferase (ASAT) level of mice treated with 300 mg/kg b.w. of HEAI extract increased when compared with the control. The results of this study support the traditional use of these plants species extracts against malaria infection in rural zones of Northern Cameroon, therefore confirming their potential as sources for the development of efficient phytomedicines for malaria-poverty disease alleviation.
机译:疟疾是非洲特别是喀麦隆最重要的传染病之一。穷人无法获得目前的治疗方法以及耐药性恶性疟原虫的出现刺激了人们寻找替代治疗方法的努力。这项研究的目的是评估从鸢尾和印度印za中提取的乙醇溶液的抗疟活性和安全性。通过在70%的乙醇中浸渍大花大黄E和plant大叶的整个植物粉末,制备大花大黄E(HEEF)和A麻(HEAI)的粗制乙醇提取物。使用小鼠模型伯氏疟原虫/ Balb C小鼠根据Peter的4天抑制试验确定抗疟活性,而分别根据OECD 425和407指南评估急性和亚急性毒性试验。结果表明,寄生虫血症的减少范围从HEAI的49.75±3.64降至69.28±1.36%,HEEI的从30.46±4.30降低至62.36±2.32%。总体而言,HEEF和HEAI的剂量为60、120和240 mg / kg b.w.分别为75、150和300 mg / kg b.w.,对感染伯氏疟原虫的BALB / c小鼠显示出明显的(p≤0.001)寄生虫病降低。与阴性对照相比,HEEF和HEAI引起小鼠体温下降的显着(p <0.001)衰减,除了150 mg / kg b.w.。女性组的剂量。而且,即使在5000mg / kg的剂量下,也没有观察到用这些提取物引起的小鼠死亡,而用300mg / kg b.w.处理的小鼠的天冬氨酸氨基转移酶(ASAT)水平。与对照相比,HEAI提取物的含量增加。这项研究的结果支持这些植物物种提取物在喀麦隆北部农村地区抗疟疾感染的传统用途,因此证实了它们作为开发有效的植物药来缓解疟疾和贫困的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号